SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 45,080,155
- Share change
- +662,227
- Total reported value
- $2,861,165,390
- Put/Call ratio
- 74%
- Price per share
- $63.44
- Number of holders
- 139
- Value change
- +$40,050,823
- Number of buys
- 77
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
8%
|
6,044,266
|
$498,108,000 | — | 30 Jun 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
7.7%
|
5,831,307
|
$480,558,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
6.4%
|
4,849,912
|
$399,681,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
5.2%
|
3,968,220
|
$327,021,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
2,706,067
|
$223,007,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
2,486,323
|
$204,897,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
2.7%
|
2,075,905
|
$171,075,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,375,775
|
$113,378,000 | — | 30 Jun 2021 | |
| Consonance Capital Management LP |
13F
|
Company |
1.6%
|
1,199,339
|
$98,838,000 | — | 30 Jun 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.4%
|
1,088,537
|
$89,706,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
1,081,921
|
$89,161,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
872,562
|
$71,907,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
812,025
|
$66,919,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
772,461
|
$63,658,000 | — | 30 Jun 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.84%
|
636,236
|
$52,432,000 | — | 30 Jun 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.75%
|
565,578
|
$46,609,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.75%
|
563,468
|
$46,435,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.74%
|
558,574
|
$46,032,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.7%
|
528,966
|
$43,592,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
503,569
|
$41,499,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.66%
|
500,000
|
$41,205,000 | — | 30 Jun 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.52%
|
392,842
|
$32,374,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
321,848
|
$26,523,000 | — | 30 Jun 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.41%
|
313,659
|
$25,849,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.41%
|
308,937
|
$25,459,000 | — | 30 Jun 2021 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.32%
|
241,337
|
$19,889,000 | — | 30 Jun 2021 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.26%
|
196,760
|
$16,215,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
196,019
|
$16,154,000 | — | 30 Jun 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.26%
|
195,117
|
$16,080,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
193,144
|
$15,917,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.25%
|
185,753
|
$15,308,000 | — | 30 Jun 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.24%
|
184,676
|
$15,219,000 | — | 30 Jun 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.22%
|
169,852
|
$13,998,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
162,521
|
$13,393,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.19%
|
140,834
|
$11,606,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.17%
|
125,879
|
$10,374,000 | — | 30 Jun 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.16%
|
117,270
|
$9,748,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
108,996
|
$8,983,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.14%
|
106,499
|
$8,777,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.14%
|
106,161
|
$8,749,000 | — | 30 Jun 2021 | |
| AXA S.A. |
13F
|
Company |
0.14%
|
103,824
|
$8,556,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
95,458
|
$7,867,000 | — | 30 Jun 2021 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
0.12%
|
91,686
|
$7,556,000 | — | 30 Jun 2021 | |
| TCW GROUP INC |
13F
|
Company |
0.12%
|
88,114
|
$7,262,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
81,201
|
$6,692,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.1%
|
75,513
|
$6,219,000 | — | 30 Jun 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.09%
|
64,634
|
$5,327,000 | — | 30 Jun 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.09%
|
64,316
|
$5,300,000 | — | 30 Jun 2021 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.08%
|
61,000
|
$5,027,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
54,746
|
$4,512,000 | — | 30 Jun 2021 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q3 2021
As of 30 Sep 2021,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,080,155 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and BANK OF AMERICA CORP /DE/.
This page lists
139
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
133
Q3 2021 holders
139
Holder diff
6
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.